See more : Enomoto Co.,Ltd. (6928.T) Income Statement Analysis – Financial Results
Complete financial analysis of Apollo Medical Holdings, Inc. (AMEH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Apollo Medical Holdings, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Nichimo Co., Ltd. (8091.T) Income Statement Analysis – Financial Results
- Nova Vision Acquisition Corporation (NOVVW) Income Statement Analysis – Financial Results
- Big Tech 50 R&D-Limited Partnership (BIGT.TA) Income Statement Analysis – Financial Results
- Tsodilo Resources Limited (TSDRF) Income Statement Analysis – Financial Results
- Jorudan Co.,Ltd. (3710.T) Income Statement Analysis – Financial Results
Apollo Medical Holdings, Inc. (AMEH)
About Apollo Medical Holdings, Inc.
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.14B | 773.92M | 370.25M | 560.62M | 519.91M | 356.36M | 57.43M | 44.05M | 32.99M | 10.48M | 7.78M | 5.11M | 3.90M | 2.44M | 1.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 944.69M | 596.14M | 348.54M | 467.81M | 361.13M | 273.45M | 48.74M | 34.00M | 22.07M | 9.08M | 6.32M | 4.13M | 3.31M | 1.81M | 1.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 199.48M | 177.77M | 21.71M | 92.81M | 158.78M | 82.90M | 8.69M | 10.05M | 10.92M | 1.41M | 1.46M | 978.41K | 581.86K | 627.51K | 11.25K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 17.43% | 22.97% | 5.86% | 16.56% | 30.54% | 23.26% | 15.14% | 22.81% | 33.11% | 13.43% | 18.77% | 19.14% | 14.93% | 25.70% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 77.67M | 62.08M | 15.59M | 41.48M | 43.35M | 26.25M | 18.58M | 16.96M | 11.28M | 5.29M | 3.52M | 1.38M | 566.65K | 694.32K | 827.29K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 77.67M | 62.08M | 15.59M | 41.48M | 43.35M | 26.25M | 18.58M | 16.96M | 11.28M | 5.29M | 3.52M | 1.38M | 566.65K | 694.32K | 827.29K | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Other Expenses | 3.94M | -3.75M | 7.69M | 3.03M | 1.62M | 168.10K | 14.70K | 239.06K | 3.03K | 49.70K | -37.25K | 2.84K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 95.21M | 79.59M | 15.62M | 58.40M | 66.55M | 45.32M | 19.23M | 17.31M | 11.62M | 5.32M | 3.54M | 1.39M | 577.85K | 730.02K | 847.07K | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Cost & Expenses | 1.04B | 675.74M | 364.16M | 526.20M | 427.68M | 318.78M | 67.96M | 51.31M | 33.68M | 14.39M | 9.85M | 5.52M | 3.89M | 2.54M | 1.89M | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Interest Income | 1.98M | 1.57M | 405.00K | 2.02M | 1.26M | 1.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 7.92M | 5.39M | 2.53M | 4.73M | 561.00K | 79.69K | 82.91K | 542.30K | 1.33M | 679.18K | 930.18K | 304.03K | 126.43K | 53.13K | 55.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 29.09M | 11.03M | 25.93M | 18.43M | 19.30M | 19.08M | 351.40K | 351.40K | 334.43K | 31.36K | 20.92K | 12.59K | 11.20K | 35.70K | 19.78K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 133.35M | 111.40M | 40.27M | 50.85M | 106.29M | 56.72M | -9.88M | -6.68M | -356.87K | -3.83M | -2.09M | -397.90K | 15.21K | -66.81K | -816.04K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| EBITDA Ratio | 11.65% | 14.39% | 10.88% | 9.07% | 20.44% | 15.92% | -17.20% | -15.16% | -1.08% | -36.52% | -26.94% | -7.79% | 0.39% | -2.74% | -77.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 104.27M | 98.18M | 6.09M | 32.42M | 88.43M | 35.15M | -10.54M | -7.27M | -694.33K | -3.91M | -2.08M | -413.34K | 4.02K | -102.52K | -835.82K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| Operating Income Ratio | 9.11% | 12.69% | 1.64% | 5.78% | 17.01% | 9.86% | -18.35% | -16.50% | -2.10% | -37.29% | -26.73% | -8.09% | 0.10% | -4.20% | -79.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -17.65M | -20.43M | 2.78M | -8.57M | -9.60M | 14.57M | 1.81M | -978.30K | -489.83K | -629.48K | -6.82M | -301.19K | -158.75K | -92.77K | -55.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 86.62M | 77.75M | 8.87M | 25.84M | 82.63M | 49.71M | -8.73M | -8.24M | -1.18M | -4.54M | -8.90M | -714.53K | -154.73K | -195.28K | -891.02K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 7.57% | 10.05% | 2.40% | 4.61% | 15.89% | 13.95% | -15.20% | -18.72% | -3.59% | -43.30% | -114.45% | -13.98% | -3.97% | -8.00% | -84.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 40.88M | 31.69M | 9.18M | 8.17M | 22.36M | 3.89M | -47.50K | -71.04K | 163.79K | 19.51K | 4.80K | 5.82K | 1.60K | 800.00 | 800.00 | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Net Income | 45.17M | 68.92M | -23.75M | 14.12M | 10.84M | 25.80M | -8.97M | -9.34M | -1.80M | -5.02M | -8.90M | -720.35K | -156.33K | -196.08K | -891.82K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| Net Income Ratio | 3.95% | 8.91% | -6.42% | 2.52% | 2.08% | 7.24% | -15.62% | -21.21% | -5.46% | -47.88% | -114.51% | -14.09% | -4.01% | -8.03% | -84.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 1.00 | 1.57 | -0.65 | 0.41 | 0.33 | 0.80 | -1.49 | -1.59 | -0.37 | -1.07 | -2.56 | -0.25 | -0.06 | -0.07 | -0.37 | -0.12 | -1.57 | -0.76 | -0.58 | -0.45 |
| EPS Diluted | 0.99 | 1.52 | -0.63 | 0.39 | 0.29 | 0.80 | -1.49 | -1.59 | -0.37 | -1.07 | -2.56 | -0.25 | -0.06 | -0.07 | -0.37 | -0.12 | -1.57 | -0.76 | -0.58 | -0.45 |
| Weighted Avg Shares Out | 44.97M | 43.83M | 36.53M | 34.71M | 32.89M | 32.30M | 6.03M | 5.88M | 4.86M | 4.70M | 3.48M | 2.93M | 2.75M | 2.65M | 2.40M | 299.70K | 17.51K | 17.51K | 17.51K | 17.51K |
| Weighted Avg Shares Out (Dil) | 45.60M | 43.83M | 37.45M | 36.40M | 37.91M | 32.30M | 6.03M | 5.88M | 4.86M | 4.70M | 3.48M | 2.93M | 2.75M | 2.65M | 2.40M | 299.70K | 17.51K | 17.51K | 17.51K | 17.51K |
Is the Options Market Predicting a Spike in Apollo Medical (AMEH) Stock?
Investors need to pay close attention to Apollo Medical (AMEH) stock based on the movements in the options market lately.
New Strong Buy Stocks for November 22nd
DCBO, APPF, AMEH, FUTU and ZEUS have been added to the Zacks Rank #1 (Strong Buy) List on November 22, 2022.
Apollo Medical Holdings, Inc. (AMEH) Q3 2022 Earnings Call Transcript
Apollo Medical Holdings, Inc. (NASDAQ:AMEH ) Q3 2022 Earnings Conference Call November 4, 2022 8:30 AM ET Company Participants Carolyne Sohn - IR Brandon Sim - Co-CEO Chan Basho - Interim CFO Conference Call Participants Ryan Daniels - William Blair...
Apollo Medical Holdings, Inc. Schedules 2022 Third Quarter Financial Results Release and Conference Call
ALHAMBRA, Calif. , Oct. 21, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of...
Apollo Medical Holdings, Inc. to Participate in Upcoming Virtual Investor Conferences
ALHAMBRA, Calif. , Sept. 21, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of...
Apollo Medical Holdings, Inc. (AMEH) Management Team on Q2 2022 Results - Earnings Call Transcript
Apollo Medical Holdings, Inc. (NASDAQ:AMEH ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Carolyne Sohn – Investor Relations Brandon Sim – Co-Chief Executive Officer Chan Basho – Chief Strategy Officer and Interim Chief Financial...
Apollo Medical Holdings, Inc. Schedules 2022 Second Quarter Financial Results Release and Conference Call
ALHAMBRA, Calif. , July 21, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of...
ApolloMed sees $9 million in insider buying; AMEH stock jumps over 6%
Apollo Medical Holdings (NASDAQ: AMEH), a market-leading physician-centric healthcare management company, has recently seen a lot of insider buying. Namely,.
7 Micro-Cap Stocks to Buy and Hold for the Next 10 Years
Finding micro-cap stocks to buy requires a bit of everything, including patience. Today's plan is to pick from the top of the IWC ETF.
Apollo Medical Holdings, Inc. to Present at Upcoming Investor Conferences
ALHAMBRA, Calif. , May 11, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of...
Source: https://incomestatements.info
Category: Stock Reports